Dauvilliers Y, Mignot E, Antczak J, Arnulf I, Barateau L, Buntinx E, Corser B, Iranzo A, Khatami R, Lammers GJ, Lederer K, Nilsen KB, Pizza F, Schmidt MH, Sivam S, Sum-Ping O, Taniguchi M, Zhan S, Abraham A, Cai A, Du Y, Etherton MR, Faessel H, Hsiao S, Kadali H, Koundourakis E, Naylor M, Neuwirth R, Olsson T, Rogers Ret al.(2026) Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials N Engl J Med(in press) DOI 10.1056/NEJMoa2601598, PubMed 42714024
Ihle-Hansen H, Ihle-Hansen H, Blauenfeldt RA, Dawson J, Diederichsen SZ, Hagberg G(2026) Cardiometabolic drugs after stroke: time to embrace SGLT2 inhibitors and incretin-based therapies? Front Stroke, 5, 1918465 DOI 10.3389/fstro.2026.1918465, PubMed 42712498
Gundersen V, Strøm NJ, Broch BB, Aarli Å, Ruud KJ(2026) Feil diagnose ved skjønnsmessig vurdering av hjernerystelse Tidsskr Nor Laegeforen, 146(10) DOI 10.4045/tidsskr.26.0127, PubMed 42709000
